Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy: toxicity, pharmacokinetics, and biological effects.
Year: 1996
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: J Lorenz, K Wilhelm, M Kessler, C Peschel, U Schwulera, R Lissner, W G Struff, E Huland, C Huber, W E Aulitzky
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1918446294